Skip to Content

Join the 'Diagnosis' group to help and get support from people like you.

Diagnosis News

Related terms: Diagnose, Diagnosed

FDA Approves Gadavist (gadobutrol) as the First MRI Contrast Agent for Patients Less Than 2 Years

Posted 7 Jan 2015 by Drugs.com

LEVERKUSEN, Germany, Jan. 5, 2015 /PRNewswire/ – Bayer HealthCare announced today that the U.S. Food and Drug Administration (FDA) has approved Gadavist (gadobutrol) injection for use with magnetic resonance imaging (MRI) in pediatric patients less than 2 years of age, including term neonates, to detect and visualize areas with disrupted blood brain barrier and/or abnormal vascularity of the ...

Ask a Question